Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBAY | TEVA | BBIO | RDY | SUPN |
| Company | Cymabay Therapeutics | Teva Pharmaceutical Industries ADR | Bridgebio Pharma Inc | Dr. Reddy's Laboratories Ltd ADR | Supernus Pharm |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 32.49 | 32.38 | 68.08 | 13.30 | 43.67 |
| High | 32.50 | 32.38 | 68.60 | 13.36 | 44.58 |
| Low | 32.48 | 30.80 | 65.59 | 13.21 | 43.54 |
| Latest | 32.48 | 31.48 | 66.27 | 13.29 | 44.38 |
| Change | +0.01 | -1.08 | -1.12 | +0.14 | +0.80 |
| % Change | +0.03% | -3.32% | -1.66% | +1.06% | +1.84% |
| Volume | 8,356,200 | 12,241,500 | 3,815,600 | 2,007,800 | 1,096,000 |
| 20-Day Average Volume | 3,390,805 | 6,359,775 | 2,797,880 | 1,531,260 | 625,940 |
| Previous Close | 32.47 | 32.56 | 67.39 | 13.15 | 43.58 |
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 32.35 | 33.88 | 67.15 | 13.35 | 45.40 |
| 20-Day Raw Stochastic | 94.12% | 14.56% | 40.80% | 37.02% | 26.15% |
| 20-Day Relative Strength | 78.00 | 41.19 | 45.85 | 48.41 | 40.78 |
| Weighted Alpha | +247.60 | +71.43 | +40.79 | -11.81 | +19.99 |
| Today's Opinion | 100% Buy | 24% Buy | 72% Sell | 96% Sell | 88% Sell |
| Previous Opinion | 100% Buy | 40% Buy | 56% Sell | 88% Sell | 88% Sell |
| Last Month's Opinion | 100% Buy | 72% Buy | 24% Sell | 88% Sell | 32% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.03% since 03/14/24 | -8.91% since 06/11/26 | -1.89% since 06/11/26 | -0.52% since 06/11/26 | -2.57% since 06/11/26 |
| Low | 32.44 on 03/15/24 | 30.80 on 06/18/26 | 65.59 on 06/18/26 | 13.08 on 06/17/26 | 42.45 on 06/16/26 |
| High | 32.50 on 03/21/24 | 35.25 on 06/15/26 | 68.61 on 06/17/26 | 13.43 on 06/15/26 | 45.71 on 06/12/26 |
| 1-Month | |||||
| %Chg | +0.90% since 02/21/24 | -7.49% since 05/18/26 | +1.45% since 05/18/26 | -2.28% since 05/18/26 | -8.17% since 05/18/26 |
| Low | 32.15 on 02/22/24 | 30.80 on 06/18/26 | 62.50 on 06/02/26 | 12.95 on 06/03/26 | 42.45 on 06/16/26 |
| High | 32.50 on 03/21/24 | 35.47 on 05/29/26 | 71.74 on 05/22/26 | 13.86 on 05/26/26 | 49.83 on 05/22/26 |
| 3-Month | |||||
| %Chg | +46.17% since 12/21/23 | +6.32% since 03/18/26 | -5.49% since 03/18/26 | -4.11% since 03/18/26 | -9.96% since 03/18/26 |
| Low | 22.11 on 01/26/24 | 27.93 on 04/06/26 | 62.50 on 06/02/26 | 12.19 on 05/12/26 | 42.45 on 06/16/26 |
| High | 32.50 on 03/21/24 | 36.99 on 05/07/26 | 84.75 on 04/28/26 | 14.31 on 03/19/26 | 52.96 on 05/06/26 |
| 6-Month | |||||
| %Chg | +122.47% since 09/21/23 | +3.83% since 12/18/25 | -10.62% since 12/18/25 | -4.66% since 12/18/25 | -9.94% since 12/18/25 |
| Low | 12.32 on 10/13/23 | 27.93 on 04/06/26 | 62.50 on 06/02/26 | 12.19 on 05/12/26 | 42.45 on 06/16/26 |
| High | 32.50 on 03/21/24 | 37.35 on 02/03/26 | 84.94 on 02/12/26 | 14.80 on 02/25/26 | 59.68 on 02/25/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,726,235 | 36,196,112 | 12,979,708 | 11,092,472 | 2,575,815 |
| Shares Outstanding, K | 114,724 | 1,149,813 | 195,861 | 834,648 | 58,040 |
| Annual Sales | 31,070,000 | 17,258,000,000 | 502,080,000 | 3,580,000,000 | 718,950,000 |
| Annual Net Income | -105,370,000 | 1,411,000,000 | -724,930,000 | 456,000,000 | -38,550,000 |
| Last Quarter Sales | 60,000 | 3,982,000,000 | 194,520,000 | 593,010,000 | 207,710,000 |
| Last Quarter Net Income | -41,900,000 | 369,000,000 | -164,040,000 | -10,780,000 | -2,290,000 |
| 60-Month Beta | 0.32 | 0.84 | 0.97 | 0.27 | 0.55 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 02/28/24 | 0.53 on 04/29/26 | -0.84 on 05/07/26 | 0.06 on 05/12/26 | 0.59 on 05/05/26 |
| Earnings Date | 05/20/24 | 07/29/26 | 08/04/26 | 07/22/26 | 08/04/26 |
| Most Recent Dividend | N/A | 0.072 on 11/27/17 | N/A | 0.071 on 07/25/25 | N/A |
| Next Ex-Dividends Date | N/A | 11/27/17 | N/A | 07/24/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 11.55 | 0.00 | 21.56 | 17.86 |